[Federal Register Volume 68, Number 52 (Tuesday, March 18, 2003)]
[Notices]
[Page 12913]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-6367]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Board to the Food and Drug Administration; Notice of 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Science Board to the Food and Drug 
Administration.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 9, 2003, from 8 
a.m. to 4:30 p.m.
    Location: Food and Drug Administration, rm. 1066, 5630 Fishers 
Lane, Rockville, MD 20857.
    Contact Person: Susan Bond, Office of the Commissioner, Food and 
Drug Administration (HF-33), 5600 Fishers Lane, Rockville, MD 20857, 
301-827-6687, [email protected], or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
12603. Please call the Information Line for up-to-date information on 
this meeting.
    Agenda: The board will hear and discuss the FDA's launched 
initiative to improve the development and availability of innovative 
medical products, specifically in the area of pharmacogenomics. The 
board will also hear updates on the pharmaceutical manufacturing 
initiative.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by March 28, 
2003. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before March 28, 2003, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Susan Bond at least 
7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 10, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-6367 Filed 3-17-03; 8:45 am]
BILLING CODE 4160-01-S